M. Giordano, A. Iadonisi
FULL PAPER
diluted with CH2Cl2 and washed with water. The aqueous phase
was re-extracted with CH2Cl2, and combined organic extracts were
dried and concentrated under vacuum. The residue was purified by
silica gel flash chromatography (eluent: hexane/ethyl acetate mix-
tures).
12.5 Hz, 1 H, 6a-H), 4.13 (br. d, J = 12.5 Hz, 1 H, 6b-H), 4.09
(br. dd, J = 6.0 and 12.5 Hz, 1 H, -OCHaHbCH=CH2), 3.74–3.64
(overlapping signals, 2-H and 5-H), 2.08, 2.02 (ϫ2) (3 s, 9 H, 3
-COCH3) ppm. 13C NMR (100 MHz, CDCl3): δ = 170.7 (ϫ2)
(-COCH3), 154.1 (-COCCl3), 133.3 (CH=CH2), 118.0 (CH=CH2),
99.6 (C-1), 95.4, 74.4, 71.7 (ϫ2), 70.2, 68.7, 62.0, 56.1 (C-2),
20.6 ppm. MALDI-TOF MS: m/z
C18H24Cl3NO10 (520.75): calcd. C 41.52, H 4.65; found C 41.25, H
4.75.
3,4,6-Tri-O-acetyl-1,2-O-(1-methoxyethylidene)-α-D-glucopyranose
= 542.80 [M +
Na]+.
(1): Diastereoisomeric ratio 11:1. 1H NMR (500 MHz, CDCl3) sig-
nals of the major diastereoisomer: δ = 5.67 (d, J = 5.0 Hz, 1 H, 1-
H), 5.17 (t, J = 3.0 Hz, 1 H, 3-H), 4.85 (dd, J = 3.0 and 9.5 Hz, 1
H, 4-H), 4.28 (m, 1 H, 2-H), 4.20–4.10 (m, 2 H, 6-H2), 3.91 (m, 1
H, 5-H), 3.24 (s, 3 H, -OCH3), 2.07, 2.05 (ϫ2) (3 s, 9 H, 3
-COCH3), 1.67 (s, 3 H, orthoester -CH3) ppm. 13C NMR
(100 MHz, CDCl3): δ = 170.6, 169.6, 169.1 (-COCH3), 121.5, 96.8
(C-1), 73.0, 70.0, 68.2, 66.9, 63.0, 20.7, 20.0 ppm. MALDI-TOF
MS: m/z = 385.30 [M + Na]+. C15H22O10 (362.33): calcd. C 49.72,
H 6.12; found C 49.85, H 6.05.
2,3,4,6-Tetra-O-acetyl-2-hydroxy-D-glucal (17): [α]D = –32.5 (c =
1.6, in CHCl3). 1H NMR (400 MHz, CDCl3): δ = 6.57 (s, 1-H),
5.49 (d, J = 4.4 Hz, 1 H, 3-H), 5.16 (dd, J = 4.4 and 5.6 Hz, 1 H,
4-H), 4.36 (dd, J = 6.4 and 11.6 Hz, 1 H, 6a-H), 4.35–4.25 (m, 1
H, 5-H), 4.16 (dd, J = 3.2 and 11.6 Hz, 1 H, 6b-H), 2.04 (ϫ2), 2.03,
1.99 (3 s, 12 H, 4 -COCH3) ppm. 13C NMR (100 MHz, CDCl3): δ
= 170.2, 169.8, 169.3, 169.2 (-COCH3), 139.1 (C-1), 127.2 (C-2),
74.0, 67.3, 66.2, 60.8, 20.5 (ϫ3), 20.2 ppm. MALDI-TOF MS: m/z
= 353.20 [M + Na]+. C14H18O9 (330.29): calcd. C 50.91, H 5.49;
found C 50.75, H 5.55.
Phenyl 2,3,4-Tri-O-acetyl-1-thio-β-L-fucopyranoside (6): [α]D =
1
–10.1 (c = 1.3, in CHCl3). H NMR (500 MHz, CDCl3): δ = 7.60–
7.20 (aromatic H), 5.25 (bd, J = 3.0 Hz, 1 H, 4-H), 5.22 (t, J =
10.0 Hz, 1 H, 2-H), 5.05 (dd, J = 3.0 and 10.0 Hz, 1 H, 3-H), 4.70
(d, J = 10.0 Hz, 1 H, 1-H), 3.83 (br. q, J = 6.5 Hz, 1 H, 5-H), 2.14,
2.08, 1.97 (3 s, 9 H, 3 -COCH3), 1.23 (d, J = 6.5 Hz, 3 H, 6-H3)
ppm. 13C NMR (100 MHz, CDCl3): δ = 170.5, 170.0, 169.4
(-COCH3), 132.3, 128.8, 127.9 (aromatic CH), 86.5 (C-1), 73.1,
72.4, 70.2, 69.0, 67.3, 20.7, 20.5 (ϫ2), 16.3 ppm. MALDI-TOF
MS: m/z = 405.15 [M + Na]+. C18H22O7S (382.43): calcd. C 56.53,
H 5.80; found C 56.40, H 5.90.
2,3,4,6-Tetra-O-acetyl-2-hydroxy-D-galactal (18): [α]D = –3.8 (c =
1.6, in CHCl3). 1H NMR (500 MHz, CDCl3): δ = 6.59 (s, 1-H),
5.80 (d, J = 4.5 Hz, 1 H, 3-H), 5.45 (dd, J = 2.0 and 5.0 Hz, 1 H,
4-H), 4.38–4.34 (m, 1 H, 5-H), 4.25 (dd, J = 3.2 and 12.0 Hz, 1 H,
6a-H), 4.16 (dd, J = 3.6 and 12.0 Hz, 1 H, 6b-H), 2.09, 2.07, 2.05,
2.00 (4 s, 12 H, 4 -COCH3) ppm. 13C NMR (100 MHz, CDCl3): δ
= 170.3, 169.8, 169.7, 169.2 (-COCH3), 138.7 (C-1), 127.1 (C-2),
73.1, 63.8 (ϫ2), 61.2, 20.5, 20.4 (ϫ2), 20.2 ppm. MALDI-TOF
MS: m/z = 353.20 [M + Na]+. C14H18O9 (330.29): calcd. C 50.91,
H 5.49; found C 50.75, H 5.55.
Methyl 3,4-Di-O-acetyl-1,2-O-(1-methoxyethylidene)-α-D-glucopyr-
anuronate (9): Diastereoisomeric ratio 10:1. 1H NMR (400 MHz,
CDCl3): δ = 5.85 (d, J = 4.8 Hz, 1 H, 1-H), 5.23 (t, J = 2.4 Hz, 1
H, 3-H), 5.15 (ddd, J = 1.2, 2.4, and 7.6 Hz, 1 H, 4-H), 4.32–4.25
(2 H, 2-H and 5-H), 3.74 (s, 3 H, -CO2CH3), 3.26 (s, 3 H, orthoes-
ter -OCH3), 2.07, 2.06 (2 s, 6 H, 2 -COCH3), 1.70 (s, 3 H, orthoester
CH3) ppm. 13C NMR (100 MHz, CDCl3): δ = 169.3, 168.7 (ϫ2)
(-COCH3 and -CO2CH3), 122.5 (orthoester C), 95.8 (C-1), 73.0,
70.3, 68.9, 68.3, 52.5, 50.5, 21.0, 20.6 ppm. MALDI-TOF MS: m/z
= 371.35 [M + Na]+ . C14H20O10 (348.31): calcd. C 48.28, H 5.79;
found C 48.40, H 5.70.
2,3,4-Tri-O-acetyl-2-hydroxy-L-fucal (19): [α]D = –6.2 (c = 1.1, in
1
CHCl3). H NMR (500 MHz, CDCl3): δ = 6.60 (d, J = 1.2 Hz, 1-
H), 5.87 (d, J = 5.2 Hz, 1 H, 4-H), 5.32 (d, J = 1.2 and 5.2 Hz, 1
H, 3-H), 4.29 (q, J = 6.4 Hz, 1 H, 5-H), 2.15, 2.10, 2.01 (3 s, 9 H,
3 -COCH3), 1.29 (d, J = 6.4 Hz, 3 H, 6-H3) ppm. 13C NMR
(100 MHz, CDCl3): δ = 170.4, 169.9, 169.3 (-COCH3), 139.3 (C-
1), 126.8 (C-2), 72.1, 66.3, 64.5, 20.5, 20.3, 16.0 ppm. MALDI-
TOF MS: m/z = 295.20 [M + Na]+. C12H16O7 (272.25): calcd. C
52.94, H 5.92; found C 52.85, H 5.95.
Methyl (Ethyl 2,3,4-Tri-O-acetyl-1-thio-β-D-glucopyranoside)uron-
2,3,4-Tri-O-acetyl-2-hydroxy-D-glucuronal Methyl Ester (20): [α]D =
ate (10): Anomeric ratio β/α, 5:1, 1H NMR (500 MHz, CDCl3)
signals of the β-anomer: δ = 5.24 (t, J = 10.0 Hz, 1 H, 3-H), 5.18
(t, J = 10.0 Hz, 1 H, 4-H), 5.03 (t, J = 10.0 Hz, 1 H, 2-H), 4.51 (d,
J = 10.0 Hz, 1 H, 1-H), 4.02 (d, J = 10.0 Hz, 1 H, 5-H), 3.72 (s, 3
H, -CO2CH3), 2.80–2.60 (m, 2 H, -SCH2CH3), 2.03, 1.99 (ϫ2) (2
s, 9 H, 3 -COCH3), 1.24 (t, J = 7.5 Hz, 3 H, -SCH2CH3) ppm.
Significant signals of the α-anomer: δ = 5.71 (d, J = 5.0 Hz, 1 H,
1-H), 5.34 (t, J = 9.5 Hz, 1 H, 3-H), 5.15 (t, J = 9.5 Hz, 1 H, 4-H),
4.98 (dd, J = 5.00 and 10.0 Hz, 1 H, 2-H), 4.73 (d, J = 9.5 Hz, 1
H, 5-H), 2.04, 2.02, 2.00 (3 s, 9 H, 3 -COCH3), 1.24 (t, J = 7.5 Hz,
3 H, -SCH2CH3) ppm. 13C NMR (100 MHz, CDCl3) signals of the
β-anomer: δ = 169.9, 169.2 (ϫ2), 166.9 (-COCH3 and -CO2CH3),
83.5 (C-1), 76.2, 73.0, 69.5, 69.3, 52.7, 24.0, 20.6, 20.5, 14.6 ppm.
MALDI-TOF MS: m/z = 401.20 [M + Na]+. C15H22O9S (378.39):
calcd. C 47.61, H 5.86; found C 47.50, H 5.95.
1
–26.4 (c = 1.2, in CHCl3). H NMR (400 MHz, CDCl3): δ = 6.81
(d, J = 1.2 Hz, 1-H), 5.45 (m, 1 H), 5.37 (m, 1 H), 4.82 (m, 5-H),
3.79 (s, 3 H, -OCH3), 2.14, 2.09, 1.99 (3 s, 9 H, 3 -COCH3) ppm.
13C NMR (100 MHz, CDCl3): δ = 169.4, 169.3, 169.2, 166.6
(-COCH3 and -CO2CH3), 139.5 (C-1), 127.5 (C-2), 72.3, 69.0, 63.5,
52.4, 20.6 (ϫ2), 20.5 ppm. MALDI-TOF MS: m/z = 339.20 [M +
Na]+. C13H16O9 (316.26): calcd. C 49.37, H 5.10; found C 49.45,
H 5.00.
Supporting Information (see footnote on the first page of this arti-
cle): Copies of the 1H and 13C NMR spectra of all synthesized
products (1–6, 9, 10, 13, 16–20).
Acknowledgments
Allyl 3,4,6-Tri-O-acetyl-2-deoxy-2-(2,2,2-trichloroethoxycarbonyl-
The NMR and MS facilities of CIMCF (“Centro Interdipartimen-
tale di Metodologie Chimico-Fisiche dell’Università di Napoli”)
are acknowledged.
amino)-β-D-glucopyranoside (16): [α]D = +4.3 (c = 1.4, in CHCl3).
1H NMR (500 MHz, CDCl3): δ = 5.80–5.65 (m, 1 H, -OCH2-
CH=CH2), 5.35–5.25 (overlapping signals, 2 H, 3-H and -CH2-
CH=CHcisHtrans), 5.18 (bd, J = 10.0 Hz, 1 H, CH2CH=CHcis
-
Htrans), 5.06 (t, J = 9.5 Hz, 1 H, 4-H), 4.67 (d, J = 9.0 Hz, 1 H, 1-
H), 4.77–4.65 (AB, J = 11.5 Hz, 1 H, -OCH2CCl3), 4.35 (br. dd, J
= 3.2 and 12.5 Hz, 1 H, -OCHaHbCH=CH2), 4.27 (dd, J = 4.5 and
[1] For a very recent review focussed on the synthetic applications
of this combined reagent, see: M. Adinolfi, A. Iadonisi, A. Pas-
tore, S. Valerio, Pure Appl. Chem. 2012, 84, 1.
130
www.eurjoc.org
© 2013 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 2013, 125–131